Viewing Study NCT03481803


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
Study NCT ID: NCT03481803
Status: COMPLETED
Last Update Posted: 2018-09-28
First Post: 2018-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IIa Study With Escalating Dose of MS1819-SD
Sponsor: AzurRx SAS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module